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Lymphomatoid granulomatosis
A report of 4 cases
U. G. LALLOO, K. COOPER, E. M. IRUSEN, B. T. LE ROUX, V. B. JOGESSAR
Summary
Only 1 case of lymphomatoid granulomatosis has previously
been reported from South Africa. Experience with 4 such
adult patients (2 blacks and 2 whites) is described. These
patients were followed up for 15 - 48 months and none
developed evidence of a lymphoma during this period. Fever,
weight loss, cough and breathlessness were prominent symp-
toms in all patients. One patient, a black woman, with a
diffuse interstitial paUern of lung involvement, had digital
clubbing - a rare accompaniment that resolved after therapy.
Dilated congestive cardiomyopathy was found in association
with pulmonary nodules in a black male patient. All 4 patients
were treated with cytotoxic regimens. The 2 patients treated
with oral cyclophosphamide and prednisolone responded
favourably. The possible explanation for paucity of reports of
lymphomatoid granulomatosis from South Africa could be
under-reporting, underdiagnosis or a true geographic/ethnic
variation in the incidence of this condition.
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Lymphomatoid granulomatosis is a lymphoreticular prolifera-
tive disorder that derives its name from the histological charac-
teristics of an inflammatory granulomatous process in associa-
tion with features of a lymphoproliferative disease.! Although
progression to lymphoma was reported to develop in approxi-
mately 12% of patients,2 it is now felt that lymphomatoid
granulomatosis is one of a variety of polymorphous T -cell
lymphomas ab inirio. 3 Lymphomatoid granulomatosis was first
described in Mrica in a white patient by Croft er al. 4 in 1980.
To the best of our knowledge no further cases have been
reported from Mrica. We describe a further 4 cases - 2 black
and 2 white patients. .
Case reports
Case 1
A 59-year-old white man was referred for evaluation of an
opacity in the right upper lobe of the lung (Fig. 1). There was
a productive cough and weight loss of 1 month's duration. The
patient had had a gastrectomy for a peptic ulcer 4· years
previously. He was a smoker. On examination there was no
clubbing, lymphadenopathy or skin lesions. Sputum examina-
tion was negative for malignant cells and acid-fast bacilli. The
patient was treated with antibiotics with no improvement.
Bronchoscopy was unhelpful and right upper lobectomy was
performed. A mass measuring approximately 15 X 6 cm was
palpated within the excised lobe. The regional lymph nodes
were biopsied. Microscopic examination showed features of
lymphomatoid granulomatosis; the lymph nodes were free of
disease. The patient was referred to the Oncology Unit where
Fig. 1. Case 1 - chest radiograph showing consolidation in the
right upper lobe.
it was elected to treat him with the MACOP + B regimen
(methotrexate, adriamycin, cyclophosphamide, oncovin,
prednisolone and bleomycin) as for lymphoma.s He completed
10 courses of this regimen. The patient had two episodes of
upper-segment deep-vein thrombosis of his lower limbs and
pulmonary embolism. The patient remains free of disease 3S
months after initial presentation.
Case 2
A 39-year-old black woman was referred with a history of a
productive cough, progressively worsening dyspnoea, weight
loss and swelling of the lower limbs of 4 months' duration.
She was class III disabled (New York Heart Association
(NYHA)). A skin rash had appeared on her lower limbs 2
months previously. Sputum culture revealed Klebsiella sp. and
she was treated with chloramphenicol at the referring hospital.
Her only other therapy was furosemide for presumed cardiac
failure but a detailed cardiac examination, including echo-
cardiography subsequently failed to confIrm this. On examina-
tion, the patient was in mild respiratory distress with a respira-
tory rate of 36/min and central cyanosis. Clubbing of the
fmgers was present. There was an indurated swelling with.
subcutaneous nodules and overlying macular erythema on the
anterior aspect of both shins. Mid-te-late inspiratory crackles
were present in both mid and lower zones of the chest.
The chest radiograph taken on admission to hospital showed
a reticulonodular inflltrate in both mid and lower zones. The
cardiac silhouette was normal. The Mantoux test was 8 mm
reactive. Pulmonary function tests showed a severe restrictive
ventilatory defect with impaired single breath-diffusing capacity
for carbon monoxide. Tests for antinuclear antibody and
rheumatoid factor were negative. Biochemical investigations
for sarcoidosis, including calcium, phosphate and serum
angiotensin-eonverting enzyme, were negative. The haemo-
globin value was 11,8 g/dl and the white cell count 7,7 X 109/1
with 38% neutrophils, 48% lymphocytes and 4% eosinophils,
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and 'the erythrocyte sedimentation rate was 91 mm/lst h
(Westergren).
A transbronchial lung biopsy was unhelpful and an open
lung b~opsy was performed. Histological ~xamination of ~e
specimen showed features of lymphomatOId granulomatOSIs.
The patient was started on cyclophosphamide 2 mg/kg/d and
prednisolone 1 mg/kg on alternate days according to the
protocol of Fauci et al. 6 There was a dramatic clinical improve-
ment, which was mirrored by the lung function test. The
patient returned to work after 6 weeks. Two episodes of
haemorrhagic cystitis not responsive to further increases in
fluid intake occurred 7 months later and necessitated with-
drawal of cyclophosphamide. Features of haemorrhagic cystitis
and schistosomiasis were found on histological examination of
the bladder-wall specimen obtained at cystoscopy. The patient
remains well 19 months after her initial presentation. She has
been on prednisolone alone for the last 12 months.
Case 3
A 70-year-old black man was admitted to hospital with a
I-year history of left pleuritic pain, non-productive cough,
anorexia and weight loss. Five years previously he had deve-
loped dyspnoea, which was attributed to congestive cardiomyo-
pathy and managed with diuretics. His dyspnoea initially
improved but recurred to the extent that he was class IV
disabled (NYHA) on presentation. He had a 20 pack year
history of smoking.
On examination, the patient was apyrexial, emaciated, had
generalised hyperpigmentation and peripheral oedema. No
clubbing, lymphadenopathy or cutaneous lesions were noted.
He was in cardiac failure, with atrial fIbrillation and mitral
tricuspid regurgitation. There were signs of consolidation of
the left lung.
Chest radiography during this admission showed total opaci-
fIcation of the left hemithorax with ipsilateral mediastinal
displacement (Fig. 2, left). Radiography 39 months previously
had shown 2 nodules, which had increased in size and number
2S months later (Fig. 2. right).
The patient was unable to perform pulmonary function
tests. An echocardiogram demonstrated impaired left ventri-
cular function. He was treated with diuretics, digoxin and
captopril with good effect.
Tru-eut biopsy of the lung (left lower lobe) was performed
and histological examination showed the characteristic features
of lymphomatoid granulomatosis.
Chlorambucil at a dose of 0,1 mg/kg/d was begun. Predniso-
lone and cyclophosphamide were not used because he was in
severe cardiac failure. Two months later his disability improved
to class Ill. However, left ventricular contraetility remained
static on repeat echocardiography and chest radiography
showed no change. Bone marrow depression necessitated cessa-
tion of chemotherapy and radiotherapy was initiated. The
patient could not complete the course owing to his poor
clinical condition. He has survived 48 months since the radio-
graphic changes were fIrst noted.
Case 4
A 26-year-old white man presented with a 2-month history
of fever, vomiting, pleuritic pain and a cough with occasional
haemoptysis while on holiday in Britain. He had lost 16 kg in
weight over the 3~ weeks preceding hospitalisation. He was
taking no drugs and had never smoked. He was fully investi-
gated at the Royal Free Hospital in London and referred to
Durban for follow-up and therapy.
The patient was pyrexial (38°C) on presentation. Chest
examination revealed bronchial breathing at the left apex. The
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Fig. 2. Case 3 - left: chest radiograph showing cardiomegaly and the nodules (arrowed) in both lung fields, which had
increased in size and number from the chest radiograph 25 months earlier. Right: radiograph 14 months later shows
progression to complete opacification of the hemithorax with collapse of the left lung.
liver was palpable 2 cm below the right costal margin and the
spleen was tipped. The rest of the physical examination showed
nothing abnormal.
Chest radiography showed multiple opacities of varying
sizes in both lung fields, some of which appeared to be
cavitating (Fig. 3).
The haemoglobin value was 11,2 g/dl; leucocyte count 4,5
X 109/1, with 68% neutrophils, 22% lymphocytes, 7% mono-
cytes, 2% eosinophils, 1% basophils, and the platelet count was
Fig. 3. Case 4 - chest radiograph showing a cavity and multiple
nodules in the left lung. A large retrocardiac mass is also present.
202 X 109/1 and erythrocyte sedimentation rate 66 mmllst h
(Westergren). Rheumatoid factor and antinuclear antibody
tests were negative and sputum examination wa~ unhelpful.
Abdominal ultrasonography showed no evid'ence of intra-
abdominal masses. Computed tomography (eT) of the abdomen
revealed several small lesions in the liver, most of which were
less than 2 cm in diameter. Liver function tests showed
nothing abnormal. Low attenuation and solid lesions were also
present in both kidneys, but no enlarged abdominal nodes
were noted.
In view of the history of hoarseness, the nasopharynx was
examined by indirect laryngoscopy. There was a small well-
defined lesion on the medial surface of the right vocal cord,
which was regarded as benign and therefore not biopsied.
Percutaneous lung biopsy showed no evidence of malignant
disease or infection. Subsequent bronchoscopy revealed that
the apical segment of the right upper lobe was narrowed by
necrotic material, but there was no other abnormality of the
bronchial tree. Histological examination was unhelpful. A
biopsy of the left kidney under ultrasonographic control pro-
duced necrotic tissue.
A diagnostic laparoscopy and subsequent laparotomy were
performed and multiple biopsies were taken from a large left
perirenal mass. Histological examination revealed that the
tissue was perirenal fat showing features of lymphomatoid
granulomatosis.
The patient was started on therapy with cyclophospamide 2
mg/kg/d orally and prednisolone 1 mg/kg on alternate days
according to the protocol of Fauci et al. 6 The temperature
settled and he has regained weight. Serial chest radiography
showed almost complete clearing of the parenchymal lung
lesions with a residual thin-walled cavity in the left upper
zone. The patient remains well 15 months after initial
presentation.
Pathology
Lung tissue was submitted for histological examination in 3-
cases. The consolidated lobectomy specimen (case 1), a wedge
of lung tissue from an open lung' biopsy (case 2) and three
cores of a Tru-cut lung biopsy (case 3) were available for
histopathological examination. In case 4 the histopathological
report was obtained from the Royal Free Hospital, London.
....------~'--~----~---~---~-- -- -- -- --
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Tissue was fIxed in 10% formaldehyde and routine paraffm
sections prepared and stained with haematoxylin and eosin,
elastic-van Gieson and Masson's trichrome stains.
Light microscopy in all 3 cases showed similar features -
vessels invaded by an angiocentric lymphoplasmacytic inflltrate
(Fig. 4). Small lymphocytes admixed with polytypic mature
and immature plasma cells, histiocytes and occasional atypical
large lymphoid cells were seen extending through the vascular
wall into the subintimal layer. None of the tissue showed
evidence of vascular occlusion or tissue necrosis. The predomi-
nant cells, smalllymphocytes, showed mild cytological atypia
in all 3 cases. In cases 1 and 3 the cellular infIltrate extended
from the bronchovascular units into surrounding interstitial
parenchyma, while in case 2 the intervening parenchyma was
within normal limits. The plasma cell population proved to be
polytypic in all cases, with demonstrable staining reactions
using both x- and A-light-chain antisera (peroxidase-anti-
peroxidase; Dakopans).
Fig. 4. Case 2 - lymphomatoid granulomatosis of the lung: an
angiocentric and angiodestructive lymphoid infiltrate involving a
small pulmonary artery.
Discussion
Lymphomatoid granulomatosis is a predominantly pulmonary
angiitis. with frequent extrapulmonary manifestations. The
skin, central nervous system and kidney are commonly
involved. Lymph node, spleen and bone marrow involvement
are less common.7 Upper respiratory tract involvement is
notably rare. 8,9 More recently,lO,11 lymphomatoid granulo-
matosis has been grouped under the entity of 'angiocentric
immunoproliferative lesions' (AILs). Jaffe lo believes that AILs
are probably neoplastic ab initio, with grade I lesions being
characterised by a predominance of small lymphoid cells with
little or no cytological atypia. Progression from grade I to II
and III is characterised by increasing cytological atypia. A
recent editorial3 in The Lancet stated that, based on immunolo-
gical phenotyping and gene re-arrangement studies, most cases
of lymphomatoid granulomatosis are, in fact, malignant
lymphomas. Angiocentric immunoproliferative lesions are
thought to represent a variant ofT-cell lymphoma. Wegener's
granulomatosis, which is essentially a granulomatous vasculitis,
is distinguished from lymphomatoid granulomatosis because
of its unique appearance on histological examination and
because it does not develop into a lymphoma. 12
The patients reported here presented with pulmonary symp-
toms, viz. cough, shortness of breath and chest pain. Cough
occurred in 56 - 80%, dyspnoea in 11 - 35% and chest pain in
13 - 15% of patients in three large series of patients with
lymphomatoid granulomatosis.I,2,13 Weight loss, which was
also'a feature in our patients, occurred in 35 - 58% of patients
in these series.
Skin involvement, the commonest extrapulmonary manifes-
tation ef lymphomatoid granulomatosis has been reported in
40 - 45% of cases.2,14 Patient 2 had erythematous macular
lesions, with subcutaneous nodules resembling erythema
nodosum. The skin lesions in this condition are variable and
take the form of subcutaneous nodules, dermal nodules,
maculopapular eruptions, macular erythema and ulcers. These
may be generalised or localised to the face, trunk, legs or arms
and may precede, occur with or follow pulmonary involvement.
Recurrences are well documented. The diagnosis of lymphoma-
toid granulomatosis may be based on the skin biopsy specimen
if the characteristic pathological changes of the condition can
be demonstrated. IS The healing of the skin lesions mirrored
the resolution of the pulmonary symptoms in our patient.
Cardiac involvement was noted in 11%(8 out of 72 patients)
of Katzenstein er al.'s2 autopsy series. Our patient 3 had
dilated congestive cardiomyopathy at the time the chest radio-
graphy showed pulmonary nodules (Fig. 2). Because primary
congestive cardiomyopathy is the cOmnlonest cause of cardiac
failure in our environment, we believe the association of
cardiomyopathy with lymphomatoid granulomatosis in patient
3 may be incidental. The clinical manifestations of cardiac
involvement with lymphomatoid granulomatosis have not been
described. The pathology of cardiac involvement has been
described by Liebow er al. I The coronary arteries were involved
by a necrotising angiitis and an atypical lymphoreticular infIl-
trate in 1 of their patients. The myocardium was also infIltrated
by lymphocytes and larger atypical reticulo-endothelial deriva-
tives. It is conceivable that if the myocardium is diffusely
involved it may manifest as cardiomyopathy. However, a
myocardial biopsy would have been necessary to prove this in
our patient. The ECG did not reflect any evidence of coronary
artery disease.
Clubbing is a rare physical sign in lymphomatoid granulo-
matosis with only I case report of this sign having been
published. 16 Patient 2 presented with clubbing, which improved
with therapy, a feature documented in the previously reported
case.
The wide range of chest radiography fIndings in our patients
reflect the spectrum of lung involvement with lymphomatoid
granulomatosis. Each of the patients in our series had a
different chest radiographic picture. Patient I presented with a
unilateral mass lesion in the upper lobe of the lung (Fig. 1).
This was noted in lout of 24 and 2 out of 16 patients in two
published reviews of chest radiography in lymphomatoid
granulomatosis.17,18 Lymphomatoid granulomatosis is included
in the differential diagnosis of diffuse interstitial lung disease
and was a feature in case 2. 1S The most common chest
radiography fmding in lymphomatoid granulomatosis is mul-
tiple nodules, which may be unilateral or bilateral. 17,18 The
radiographs of patient 3 in our series showed multiple unilateral
nodules (Fig. 2), which progressed to total opacifIcation of the
left lung fIeld over a period of 39 months without therapy
(Fig. 2). Patient 4 had multiple nodular opacities, some of
which appeared to cavitate - a feature that has been well
documented. 17,18
In case 4 the diagnosis of lymphomatoid granulomatosis was
made on histological examination of the biopsy of a perirenal
mass, which turned out to be perirenal fat involved with
lymphomatoid granulomatosis. Liebow er al. I reported the
involvement of abdominal fascia at necropsy in 1 patient in
their original series. Our patient appeared to have, in addition,
involvement of the liver as noted on CT and his spleen was
clinically enlarged.
The therapy of lymphomatoid granulomatosis remains
controversial. This is because the condition is relatively rare
and most case series are retrospective studies. Although the
278 SAMJ VOL 79 2 MAR 1991
clinical course is variable, with a propensity for evolving into a
lymphoma, long-term survival without therapy has been docu-
mented. 19 Steroids alone appear inadequate to induce and/or
maintain remission. A combination of cyclophosphamide 2
mg/kg/d body weight daily and prednisolone I mglkg on alter-
nate days appeared to be effective in inducing and maintaining
complete remission in 7 out of 13 patients in a prospective
therapeutic trial.6 Malignant lymphoma developed in 7 out of
the 8 patients who died and within this group only 2 had
received therapy over an adequate period of time. The
lymphoma that develops is refractory to therapy. Patie.nt I in
our series is disease-free 35 months after initial presentation.
Cyclophosphamide and prednisolone were used with success
in patients 2 and 4. However, haemorrhagic cystitis, a known
complication of cyclophosphamide therapy20 necessitated
premature withdrawal of this drug in patient 2. Patient 3
survived 48 months without therapy although the disease
progressed radiographically.
The prognosis in lymphomatoid granulomatosis is extremely
poor with a mortality rate of 65 - 90%.6 The median survival
time in Katzenstein er al.'52 ser:ies was 14 months and 94% of
the deaths occurred by 36 months. Early recognition and
adequate chemotherapy may alter this poor prognosis.6
We have added 4 cases to the only other reported case of
lymphomatoid granulomatosis from South Mrica. The spec-
trum of disease demonstrated in our patients is similar to that
reported in other series. Clubbing, which appears to be rare,
was present in 1 patient. -The association of lymphomatoid
granulomatosis with cardiomyopathy, which was present in
case 3, has not been previously documented. The favourable
response to oral cyclophosphamide and prednisolone supports
the findings of Fauci er al. 6 During the follow-up period of
15 - 48 months, none of the patients in our series developed
evidence of a lymphoma.
The possible explanation for the paucity of reports of
lymphomatoid granulomatosis from South Africa could be
under-reporting or under-diagnosis - the condition being
eclipsed by a high background prevalence of tuberculosis in
blacks or, less likely, a true geographic/ethnic variation in
incidence in this part of the world.
The authors thank the doctors of the Royal Free Hospital in
London for referring patient 4, and are grateful to Ms Previna
Ramhorry for secretarial assistance.
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